The global Diabetes Drug Therapy market was valued at US$ 9980.8 million in 2022 and is projected to reach US$ 18920 million by 2029, at a CAGR of 9.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
This report aims to provide a comprehensive presentation of the global market for Diabetes Drug Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Drug Therapy. This report contains market size and forecasts of Diabetes Drug Therapy in global, including the following market information:
- Global Diabetes Drug Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Drug Therapy include Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Sanofi and Novo Nordisk, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Drug Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Drug Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Drug Therapy Market Segment Percentages, by Type, 2022 (%)
- Oral
- Subcutaneous
- Intravenous
Global Diabetes Drug Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Drug Therapy Market Segment Percentages, by Application, 2022 (%)
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Global Diabetes Drug Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Drug Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Drug Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Drug Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Mannkind Corporation
- Bristol Myers Squibb
- Medtronic
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline
- Sanofi
- Novo Nordisk
- Novartis International AG
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Diabetes Drug Therapy, market overview.
- Chapter 2: Global Diabetes Drug Therapy market size in revenue.
- Chapter 3: Detailed analysis of Diabetes Drug Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Diabetes Drug Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Drug Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Drug Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Drug Therapy Overall Market Size
2.1 Global Diabetes Drug Therapy Market Size: 2022 VS 2029
2.2 Global Diabetes Drug Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Drug Therapy Players in Global Market
3.2 Top Global Diabetes Drug Therapy Companies Ranked by Revenue
3.3 Global Diabetes Drug Therapy Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Drug Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Drug Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Drug Therapy Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Drug Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Drug Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Drug Therapy Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Subcutaneous
4.1.4 Intravenous
4.2 By Type - Global Diabetes Drug Therapy Revenue & Forecasts
4.2.1 By Type - Global Diabetes Drug Therapy Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Drug Therapy Revenue, 2024-2029
4.2.3 By Type - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Drug Therapy Market Size, 2022 & 2029
5.1.2 Online Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Diabetes Drug Therapy Revenue & Forecasts
5.2.1 By Application - Global Diabetes Drug Therapy Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Drug Therapy Revenue, 2024-2029
5.2.3 By Application - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetes Drug Therapy Market Size, 2022 & 2029
6.2 By Region - Global Diabetes Drug Therapy Revenue & Forecasts
6.2.1 By Region - Global Diabetes Drug Therapy Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Drug Therapy Revenue, 2024-2029
6.2.3 By Region - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetes Drug Therapy Revenue, 2018-2029
6.3.2 US Diabetes Drug Therapy Market Size, 2018-2029
6.3.3 Canada Diabetes Drug Therapy Market Size, 2018-2029
6.3.4 Mexico Diabetes Drug Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetes Drug Therapy Revenue, 2018-2029
6.4.2 Germany Diabetes Drug Therapy Market Size, 2018-2029
6.4.3 France Diabetes Drug Therapy Market Size, 2018-2029
6.4.4 U.K. Diabetes Drug Therapy Market Size, 2018-2029
6.4.5 Italy Diabetes Drug Therapy Market Size, 2018-2029
6.4.6 Russia Diabetes Drug Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Diabetes Drug Therapy Market Size, 2018-2029
6.4.8 Benelux Diabetes Drug Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetes Drug Therapy Revenue, 2018-2029
6.5.2 China Diabetes Drug Therapy Market Size, 2018-2029
6.5.3 Japan Diabetes Drug Therapy Market Size, 2018-2029
6.5.4 South Korea Diabetes Drug Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Diabetes Drug Therapy Market Size, 2018-2029
6.5.6 India Diabetes Drug Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetes Drug Therapy Revenue, 2018-2029
6.6.2 Brazil Diabetes Drug Therapy Market Size, 2018-2029
6.6.3 Argentina Diabetes Drug Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Drug Therapy Revenue, 2018-2029
6.7.2 Turkey Diabetes Drug Therapy Market Size, 2018-2029
6.7.3 Israel Diabetes Drug Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetes Drug Therapy Market Size, 2018-2029
6.7.5 UAE Diabetes Drug Therapy Market Size, 2018-2029
7 Diabetes Drug Therapy Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Diabetes Drug Therapy Major Product Offerings
7.1.4 Abbott Laboratories Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Mannkind Corporation
7.2.1 Mannkind Corporation Company Summary
7.2.2 Mannkind Corporation Business Overview
7.2.3 Mannkind Corporation Diabetes Drug Therapy Major Product Offerings
7.2.4 Mannkind Corporation Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.2.5 Mannkind Corporation Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb Diabetes Drug Therapy Major Product Offerings
7.3.4 Bristol Myers Squibb Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 Medtronic
7.4.1 Medtronic Company Summary
7.4.2 Medtronic Business Overview
7.4.3 Medtronic Diabetes Drug Therapy Major Product Offerings
7.4.4 Medtronic Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.4.5 Medtronic Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Diabetes Drug Therapy Major Product Offerings
7.5.4 AstraZeneca Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Company Summary
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company Diabetes Drug Therapy Major Product Offerings
7.6.4 Eli Lilly and Company Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly and Company Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Diabetes Drug Therapy Major Product Offerings
7.7.4 GlaxoSmithKline Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Diabetes Drug Therapy Major Product Offerings
7.8.4 Sanofi Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Novo Nordisk
7.9.1 Novo Nordisk Company Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Diabetes Drug Therapy Major Product Offerings
7.9.4 Novo Nordisk Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.9.5 Novo Nordisk Key News & Latest Developments
7.10 Novartis International AG
7.10.1 Novartis International AG Company Summary
7.10.2 Novartis International AG Business Overview
7.10.3 Novartis International AG Diabetes Drug Therapy Major Product Offerings
7.10.4 Novartis International AG Diabetes Drug Therapy Revenue in Global Market (2018-2023)
7.10.5 Novartis International AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Drug Therapy Market Opportunities & Trends in Global Market
Table 2. Diabetes Drug Therapy Market Drivers in Global Market
Table 3. Diabetes Drug Therapy Market Restraints in Global Market
Table 4. Key Players of Diabetes Drug Therapy in Global Market
Table 5. Top Diabetes Drug Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Drug Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Drug Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Drug Therapy Product Type
Table 9. List of Global Tier 1 Diabetes Drug Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Drug Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetes Drug Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Drug Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Diabetes Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetes Drug Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Drug Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Diabetes Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetes Drug Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Drug Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Diabetes Drug Therapy Product Offerings
Table 32. Abbott Laboratories Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Mannkind Corporation Company Summary
Table 35. Mannkind Corporation Diabetes Drug Therapy Product Offerings
Table 36. Mannkind Corporation Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Mannkind Corporation Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb Diabetes Drug Therapy Product Offerings
Table 40. Bristol Myers Squibb Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. Medtronic Company Summary
Table 43. Medtronic Diabetes Drug Therapy Product Offerings
Table 44. Medtronic Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Medtronic Key News & Latest Developments
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Diabetes Drug Therapy Product Offerings
Table 48. AstraZeneca Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Diabetes Drug Therapy Product Offerings
Table 52. Eli Lilly and Company Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Diabetes Drug Therapy Product Offerings
Table 56. GlaxoSmithKline Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Diabetes Drug Therapy Product Offerings
Table 60. Sanofi Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Novo Nordisk Company Summary
Table 63. Novo Nordisk Diabetes Drug Therapy Product Offerings
Table 64. Novo Nordisk Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Novo Nordisk Key News & Latest Developments
Table 66. Novartis International AG Company Summary
Table 67. Novartis International AG Diabetes Drug Therapy Product Offerings
Table 68. Novartis International AG Diabetes Drug Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis International AG Key News & Latest Developments
List of Figures
Figure 1. Diabetes Drug Therapy Segment by Type in 2022
Figure 2. Diabetes Drug Therapy Segment by Application in 2022
Figure 3. Global Diabetes Drug Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Drug Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetes Drug Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Drug Therapy Revenue in 2022
Figure 8. By Type - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetes Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetes Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 16. US Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 28. China Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetes Drug Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetes Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Mannkind Corporation Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Medtronic Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AstraZeneca Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly and Company Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novo Nordisk Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis International AG Diabetes Drug Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
